{"id":"https://openalex.org/W2595825517","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.4557","title":"Time to testosterone (T) and PSA rises during first \u201coff treatment\u201d interval (1OFF-2ON) of intermittent androgen deprivation (IAD) as prognostic for time to castration resistance (CRPC) and prostate cancer mortality (PCM) in men with biochemical relapse (BR).","display_name":"Time to testosterone (T) and PSA rises during first \u201coff treatment\u201d interval (1OFF-2ON) of intermittent androgen deprivation (IAD) as prognostic for time to castration resistance (CRPC) and prostate cancer mortality (PCM) in men with biochemical relapse (BR).","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2595825517","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.4557","mag":"2595825517"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.4557","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.4557","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.4557","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084909001","display_name":"Evan Y. Yu","orcid":"https://orcid.org/0000-0002-1510-8044","observed_orcids":["https://orcid.org/0000-0002-1510-8044"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Y. Yu","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002278514","display_name":"Kevin F Kuo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin F Kuo","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023302135","display_name":"Rachel A. Hunter\u2010Merrill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel Hunter-Merrill","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044591528","display_name":"Roman Gulati","orcid":"https://orcid.org/0000-0002-7592-6567","observed_orcids":["https://orcid.org/0000-0002-7592-6567"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roman Gulati","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034856868","display_name":"Suzanne P Hall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne P Hall","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010530707","display_name":"Teresa E Gambol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teresa E Gambol","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064344218","display_name":"Ruth Etzioni","orcid":"https://orcid.org/0000-0002-9164-6370","observed_orcids":["https://orcid.org/0000-0002-9164-6370"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruth D Etzioni","raw_affiliation_strings":["University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001591556","display_name":"Celestia S. Higano","orcid":"https://orcid.org/0000-0001-5308-8972","observed_orcids":["https://orcid.org/0000-0001-5308-8972"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Celestia S. Higano","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"4557","last_page":"4557"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11146","display_name":"Hormonal and reproductive studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intermittent-androgen-deprivation-therapy","display_name":"intermittent androgen deprivation therapy","score":0.9110000133514404},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.7400000095367432},{"id":"https://openalex.org/keywords/biochemical-recurrence","display_name":"biochemical recurrence","score":0.9120000004768372},{"id":"https://openalex.org/keywords/castration-resistance","display_name":"castration resistance","score":0.8420000076293945},{"id":"https://openalex.org/keywords/prostate-cancer-mortality","display_name":"prostate cancer mortality","score":0.7979999780654907},{"id":"https://openalex.org/keywords/testosterone","display_name":"testosterone","score":0.5040000081062317},{"id":"https://openalex.org/keywords/psa-doubling-time","display_name":"PSA doubling time","score":0.8009999990463257},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7490000128746033},{"id":"https://openalex.org/keywords/leuprolide-acetate","display_name":"leuprolide","score":0.8629999756813049},{"id":"https://openalex.org/keywords/flutamide","display_name":"flutamide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8614020347595215},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7557268142700195},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.6888125538825989},{"id":"https://openalex.org/C2778313021","wikidata":"https://www.wikidata.org/wiki/Q418669","display_name":"Flutamide","level":5,"score":0.6173803806304932},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.6069778800010681},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5307970643043518},{"id":"https://openalex.org/C48900799","wikidata":"https://www.wikidata.org/wiki/Q1424376","display_name":"Doubling time","level":3,"score":0.5106449723243713},{"id":"https://openalex.org/C2779279991","wikidata":"https://www.wikidata.org/wiki/Q6058681","display_name":"Testosterone (patch)","level":2,"score":0.504602313041687},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47354644536972046},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4596862494945526},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.444012850522995},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.42703476548194885},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34067389369010925},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.1956120729446411},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.16087624430656433},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.4557","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.4557","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.4557","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2589801922","https://openalex.org/W2082415979","https://openalex.org/W2109809089","https://openalex.org/W1982741797","https://openalex.org/W2242087265","https://openalex.org/W4237200075","https://openalex.org/W2321567540","https://openalex.org/W2246026559","https://openalex.org/W2007700273","https://openalex.org/W2030082147"],"abstract_inverted_index":{"4557":[0],"Background:":[1],"A":[2,201,221],"recent":[3],"phase":[4],"III":[5],"trial":[6,41],"of":[7,16,42,74,77,116,160,219,246,251,254,264,274,289],"intermittent":[8],"vs.":[9],"continuous":[10],"AD":[11,22,94],"supports":[12],"IAD":[13,43],"as":[14,108],"standard":[15],"care":[17],"for":[18,23,187,298,314],"men":[19,45,60],"treated":[20,68],"with":[21,46,61,69,112,163,212,237,256],"BR.":[24],"To":[25],"identify":[26],"potential":[27],"prognostic":[28,297,313],"factors":[29],"during":[30],"1OFF,":[31],"times":[32,53],"to":[33,52,54,122,129,136,196,206,226,293,301],"T":[34,88],"and":[35,56,79,89,141,165,192,278,307],"PSA":[36,90,98,110,131,138,142,151,156,227,303],"rises":[37,111],"from":[38,118,126,154,229],"our":[39],"prospective":[40],"in":[44,50,204,216,224,243,272],"BR":[47,62],"were":[48,67,91,120,167,260,263],"analyzed":[49],"relation":[51],"CRPC":[55,164,257,275],"PCM.":[57,220,299],"Methods:":[58],"72":[59],"after":[63,232,305,308],"definitive":[64],"local":[65],"therapy":[66],"IAD,":[70,290],"each":[71],"cycle":[72],"consisting":[73],"9":[75],"months":[76],"leuprolide":[78],"flutamide":[80],"followed":[81,92],"by":[82,276,280],"a":[83,100,213,238,269],"variable":[84],"\u201coff":[85,286],"treatment\u201d":[86,287],"interval.":[87],"monthly;":[93],"was":[95,183,209,234],"resumed":[96],"when":[97],"reached":[99],"pre-specified":[101],"value.":[102],"Cycles":[103],"repeated":[104],"until":[105],"CRPC,":[106,247],"defined":[107],"\u22652":[109],"T\u226450":[113],"ng/dL.":[114],"Markers":[115],"interest":[117],"1OFF-2ON":[119],"time":[121,125,135,144,205,225,292],"first":[123,127,130,137,149,155,207,285,294,302,309],"T>50,":[124],"T>50":[128,208,233,295,310],"rise":[132,139,228,304],"\u22650.1":[133],"ng/mL,":[134],"\u22650.1,":[140],"doubling":[143],"(PSAdt),":[145],"calculated":[146],"using":[147,169],"the":[148,178,217,244,252,284,291],"3":[150],"measurements":[152],"starting":[153],"\u22650.1.":[157],"The":[158],"associations":[159,253],"these":[161],"markers":[162],"PCM":[166,259,279],"evaluated":[168],"Cox":[170,179],"proportional":[171,180],"hazards":[172,181],"models":[173],"(or":[174],"logistic":[175],"regression":[176],"if":[177],"assumption":[182],"not":[184],"met),":[185],"controlling":[186],"age":[188],"at":[189],"study":[190],"entry":[191],"Gleason":[193],"score":[194],"categorized":[195],"\u22647":[197],"or":[198,231,240,258],">7.":[199],"Results:":[200],"30-day":[202,222],"increase":[203,215,223],"significantly":[210,235],"associated":[211,236],"75%":[214],"risk":[218,245,273],"1OFF":[230,306],"23%":[239],"72%":[241],"reduction":[242,271],"respectively.":[248],"While":[249],"neither":[250],"PSAdt":[255,267],"significant,":[261],"they":[262],"moderate":[265,270],"size:":[266],"displayed":[268],"35%":[277],"38%.":[281],"Conclusions:":[282],"During":[283],"interval":[288],"is":[296],"Time":[300],"are":[311],"both":[312],"CRPC.":[315],"[Table:":[316],"see":[317],"text]":[318]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-03-23T00:00:00"}